Megyesfalvi, Zsolt; Barany, Nandor; Lantos, Andras; Valko, Zsuzsanna; Pipek, Orsolya; Lang, Christian; Schwendenwein, Anna; Oberndorfer, Felicitas; Paku, Sandor; Ferencz, Bence; Dezso, Katalin; Fillinger, Janos; Lohinai, Zoltan; Moldvay, Judit; Galffy, Gabriella; Szeitz, Beata; Rezeli, Melinda; Rivard, Christopher; Hirsch, Fred R.; Brcic, Luka; Popper, Helmut; Kern, Izidor; Kovacevic, Mile; Skarda, Jozef; Mittak, Marcel; Marko-Varga, Gyorgy; Bogos, Krisztina; Renyi-Vamos, Ferenc; Hoda, Mir Alireza; Klikovits, Thomas; Hoetzenecker, Konrad; Schelch, Karin; Laszlo, Viktoria; Dome, Balazs

Utility of Telomerase Gene Mutation Testing in Patients with Idiopathic Pulmonary Fibrosis in Routine Practice

CELLS

IF5.2

2022-01-223

OAAI

Heterogeneous Response of Airway Eosinophilia to Anti-IL-5 Biologics in Severe Asthma Patients

JOURNAL OF PERSONALIZED MEDICINE

IF3

2022-01-074

OAAI

COVID-19 Pulmonary Pathology: The Experience of European Pulmonary Pathologists throughout the First Two Waves of the Pandemic

DIAGNOSTICS

IF3.3

2022-01-016

OAAI

P14/ARF-Positive Malignant Pleural Mesothelioma: A Phenotype With Distinct Immune Microenvironment

FRONTIERS IN ONCOLOGY

IF3.3

2021-03-229

OAAI

Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future

ESMO OPEN

IF8.3

2021-02-0111

OAAI

Hofman, P.; Ilie, M.; Chamorey, E.; Brest, P.; Schiappa, R.; Nakache, V; Antoine, M.; Barberis, M.; Begueret, H.; Bibeau, F.; Bonnetaud, C.; Bostroem, P.; Brousset, P.; Bubendorf, L.; Carvalho, L.; Cathomas, G.; Cazes, A.; Chalabreysse, L.; Chenard, M-P; Copin, M-C; Cote, J-F; Damotte, D.; de Leval, L.; Delongova, P.; de Montpreville, V. Thomas; de Muret, A.; Dema, A.; Dietmaier, W.; Evert, M.; Fabre, A.; Forest, F.; Foulet, A.; Garcia, S.; Garcia-Martos, M.; Gibault, L.; Gorkiewicz, G.; Jonigk, D.; Gosney, J.; Hofman, A.; Kern, I; Kerr, K.; Kossai, M.; Kriegsmann, M.; Lassalle, S.; Long-Mira, E.; Lupo, A.; Mamilos, A.; Matej, R.; Meilleroux, J.; Ortiz-Villalon, C.; Panico, L.; Panizo, A.; Papotti, M.; Pauwels, P.; Pelosi, G.; Penault-Llorca, F.; Pop, O.; Pote, N.; Cajal, S. R. Y.; Sabourin, J-C; Salmon, I; Sajin, M.; Savic-Prince, S.; Schildhaus, H-U; Schirmacher, P.; Serre, I; Shaw, E.; Sizaret, D.; Stenzinger, A.; Stojsic, J.; Thunnissen, E.; Timens, W.; Troncone, G.; Werlein, C.; Wolff, H.; Berthet, J-P; Benzaquen, J.; Marquette, C-H; Hofman, V; Calabrese, F.

T2-high Asthma, Classified by Sputum mRNA Expression of IL4, IL5, and IL13, is Characterized by Eosinophilia and Severe Phenotype

LIFE-BASEL

IF3.4

2021-01-272

OAAI

Morphologic and molecular classification of lung neuroendocrine neoplasms

VIRCHOWS ARCHIV

IF3.1

2021-01-2148

OAAI

Prognostic value of PD-L1 expression in patients with unresectable stage III non-small cell lung cancer treated with chemoradiotherapy

PD-L1表达在不可切除的 ⅲ 期非小细胞肺癌放化疗患者中的预后价值